Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic acid tests have become the gold-standard for diagnostic testing for covid-19,…
Ended Project Grant Awarded Last action
- Award ID
- R44DE030841
- Recipient
-
Quicksilver Biosciences Inc. UEI ZMEHBJ39DWK1
- Awarding agency
-
National Institute of Dental and Craniofacial Research
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,347,607
Award facts
- Assistance listing
- 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development
- Completion date
- Originally
- Funding
-
- $2,530,272.00 Federal
- $817,335.00 Non-federal
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Description
Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic acid tests have become the gold-standard for diagnostic testing for covid-19, usually performed in specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction (QRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi- cally several days. The few rapid (
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $447,801 | $0 | |
| Amendment | $447,801 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $817,335 | $0 | |
| Original award | $817,335 | $817,335 |
Show all 19
Quick answers
Who received award R44DE030841?
R44DE030841 was awarded to Quicksilver Biosciences Inc. by National Institute of Dental and Craniofacial Research (National Institutes of Health) on December 21, 2020.
How much is award R44DE030841 worth?
$3,347,607 has been obligated on R44DE030841: $2,530,272 in federal funding and $817,335 in non-federal funding.
Which agency awarded R44DE030841?
National Institute of Dental and Craniofacial Research (National Institutes of Health) awarded R44DE030841, with funding from Office of the Director (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award